In a study which enrolled about 41,500 patients, GLP1-RA were associated with a reduced risk of non-fatal MI, a composite of all cause-death, non-fatal MI, non-fatal stroke, and stable angina compared to SGLT2i, while no difference was detected in the incidence of HF hospitalization and stroke between the two groups. The gene discussed is GLP1R; the disease is Stroke.